Civil Hospices of Lyon
Inflammatory Bowel Diseases (IBD) go through two phases: flare and remission. Prediction of flares and identification of patients in remission but at high risk of flare are a major issue when taking care of IBD patients. Considering close interactions between sleep, immunity and intestinal inflammation, sleep disorders could be a predictor of flares. The purpose of this study is to demonstrate that sleep efficacy decreases before IBD flare. Patients in remission will be assessed for IBD symptoms (activity scores, biological factors) and sleep disorders (actigraphy, DREEM®, questionnaires) during one year.
Disease Bowel
Crohn Disease
Ulcerative Colitis
Sleep activity
Questionnaires
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 216 participants |
Masking : | NONE |
Primary Purpose : | OTHER |
Official Title : | Evaluation of Sleep Changes As Early Markers of Relapse in Patients with Inflammatory Bowel Diseases (IBD). |
Actual Study Start Date : | 2025-01-01 |
Estimated Primary Completion Date : | 2028-01-01 |
Estimated Study Completion Date : | 2028-01-01 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 65 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Clermont-Ferrand University Hospital, Estaing Hospital
Clermont-Ferrand, France, 63100
Not yet recruiting
CHU Grenoble Michallon Hospital-North Site
Grenoble, France, 38700
Not yet recruiting
Lyon Sud hospital
Pierre-Bénite, France, 69310
Not yet recruiting
Chu Saint ATN
Saint Etienne, France, 42270